advertisement
Okumichi H 9
Showing records 1 to 9 | Display all abstracts from Okumichi H80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sakamoto E
Scientific reports 2019; 9: 3755
80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Ibrahim DG
Cell biochemistry and function 2019; 37: 113-124
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Ishida W
Scientific reports 2019; 9: 3755
80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Ko JA
Cell biochemistry and function 2019; 37: 113-124
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Sumi T
Scientific reports 2019; 9: 3755
80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Iwata W; Okumichi H
Cell biochemistry and function 2019; 37: 113-124
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Kishimoto T
Scientific reports 2019; 9: 3755
80494 An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor
Kiuchi Y
Cell biochemistry and function 2019; 37: 113-124
80580 Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
Tada K; Fukuda K; Yoneda T; Kuroiwa H; Terao E; Fujisawa Y; Nakakura S; Jian K; Okumichi H; Kiuchi Y; Fukushima A
Scientific reports 2019; 9: 3755
